Market closed
McKesson/$MCK
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About McKesson
McKesson Corporation is a provider of diversified healthcare services. The Company is engaged in advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over the counter (OTC) pharmaceutical drugs and other healthcare-related products in the United States. Its Prescription Technology Solutions segment helps solve medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Its Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home healthcare agencies. Its International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada.
Ticker
$MCK
Sector
NON_CLASSIFIED
Trading on
NYSE
Industry
Major Drugs
Headquarters
Irving, United States
Employees
45,000
Website
McKesson Metrics
BasicAdvanced
$74B
25.47
$22.36
0.47
$2.32
0.44%
Price and volume
Market cap
$74B
Beta
0.47
52-week high
$570.59
52-week low
$383.82
Average daily volume
14M
Dividend rate
$2.32
Financial strength
Current ratio
0.916
Quick ratio
0.512
Dividend payout ratio (TTM)
8.23%
Enterprise value to free cash flow
27.007
Interest coverage (TTM)
15.05%
Management effectiveness
Return on assets (TTM)
4.87%
Return on investment (TTM)
22.01%
Valuation
Price to earnings (TTM)
25.469
Price to revenue (TTM)
0.24
Price to free cash flow (TTM)
22.348
Five year average dividend yield
0.61%
Dividend yield (TTM)
0.41%
Forward dividend yield
0.44%
Growth
Revenue change (TTM)
11.65%
Earnings per share change (TTM)
-10.83%
3-year revenue growth (CAGR)
9.05%
3-year dividend per share growth (CAGR)
11.80%
What the Analysts think about McKesson
Analyst Ratings
Majority rating from 19 analysts.
McKesson Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q4 24
QoQ growth
Revenue
$76B
-5.62%
Net income
$791M
34.30%
Profit margin
1.03%
43.06%
McKesson Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q1 24
Q2 24
Q3 24
Q4 24
Q1 25
Actual
$7.27
$6.23
$7.74
$6.18
-
Expected
$5.87
$6.15
$7.05
$6.34
$7.23
Surprise
23.94%
1.33%
9.82%
2.59%
-
McKesson News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for McKesson stock?
McKesson (MCK) has a market cap of $74B as of April 25, 2025.
What is the P/E ratio for McKesson stock?
The price to earnings (P/E) ratio for McKesson (MCK) stock is 25.47 as of April 25, 2025.
Does McKesson stock pay dividends?
Yes, the McKesson (MCK) stock pays dividends to shareholders. As of April 25, 2025, the dividend rate is $2.32 and the yield is 0.44%. McKesson has a payout ratio of 8.23% on a trailing twelve-month basis.
When is the next McKesson dividend payment date?
The next McKesson (MCK) dividend payment date is unconfirmed.
What is the beta indicator for McKesson?
McKesson (MCK) has a beta rating of 0.47. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.